Apple, which had been the top smartphone seller in China for several years, fell to third place last year behind Chinese companies such as Vivo and Huawei.

Beam is pursuing a long-term, staged development strategy for sickle cell disease that includes three “waves” of ...

More Than 40 Adult Sickle Cell Disease Patients Now Enrolled in BEACON Trial of BEAM-101; Beam Expects to Dose 30 Patients and Present Updated ...

ESCAPE: Beam's wave 2 approach is its Engineered Stem Cell Antibody Evasion (ESCAPE) platform, which aims to provide the same ex vivo-manufactured cell product deployed in wave 1, but now using a ...

But in vivo CAR-Ts are not a far-off pipe dream ... with VivoVec [Umoja’s proprietary viral vector], it'll be manufactured in our facility in Colorado and shipped and stored globally in a ...

Improvements in the latter half of 2024 could continue or even improve in 2025 according to the National Association of ...

Matti Beshay, Head of the Trade Committee at the Importers Division of the Federation of Egyptian Chambers of Commerce ...

United Therapeutics has purchased a property near its Silver Spring home base. It's latest in a string of real estate ...

ImmunityBio, Inc. , a leading immunotherapy company, today announced significant progress in its ongoing discussions with the U.S. Food and Drug Administration (FDA) regarding three areas of its ...

The AP team selects their favourite kit of 2024, read on to see an inspiring medley of the most-liked gear The post Our favourite kit of 2024 appeared first on Amateur Photographer.

India is progressing in cell and gene therapy. Research includes treatments for leukemia, hemophilia-A, sickle-cell anemia, ...